Bryan Hanson Biography and Net Worth

CEO of Zimmer Biomet

Prior to joining Zimmer Biomet, Mr. Hanson served as a member of Medtronic’s Executive Committee and as Executive Vice President and Group President, Minimally Invasive Therapies Group of Medtronic, where he oversaw and provided strategic direction to that approximately $9 billion business. Prior to joining Medtronic, Mr. Hanson served as Group President, Covidien, with global responsibility for all Covidien business segments. Prior to being elevated to that newly created position, Mr. Hanson served as Group President, Medical Devices & U.S. of Covidien and prior to that, he served as Group President, Surgical Solutions and President, Energy-based Devices. Mr. Hanson began his career with Covidien in 1992. He holds a Bachelor of Science degree in Finance from Florida State University. He also completed the Kellogg School of Management Finance for Executives program in 2010 and the Harvard Executive Education in Leadership program in 2013. Mr. Hanson serves on the board of AmeriCares, an emergency response and global health organization committed to saving lives and building healthier futures for people in crisis.

What is Bryan C. Hanson's net worth?: The estimated net worth of Bryan C. Hanson is at least $5.96 million as of May 13th, 2020. Mr. Hanson owns 54,568 shares of Zimmer Biomet stock worth more than $5,964,828 as of November 21st. This net worth estimate does not reflect any other investments that Mr. Hanson may own. Learn More about Bryan C. Hanson's net worth.
How do I contact Bryan C. Hanson?: The corporate mailing address for Mr. Hanson and other Zimmer Biomet executives is 345 EAST MAIN STREET, WARSAW IN, 46580. Zimmer Biomet can also be reached via phone at (574) 267-6131 and via email at [email protected]. Learn More on Bryan C. Hanson's contact information.
Has Bryan C. Hanson been buying or selling shares of Zimmer Biomet?: Bryan C. Hanson has not been actively trading shares of Zimmer Biomet during the past quarter. Most recently, on Wednesday, May 13th, Bryan C. Hanson bought 1,000 shares of Zimmer Biomet stock. The stock was acquired at an average cost of $113.00 per share, with a total value of $113,000.00. Following the completion of the transaction, the chief executive officer now directly owns 54,568 shares of the company's stock, valued at $6,166,184. Learn More on Bryan C. Hanson's trading history.
Who are Zimmer Biomet's active insiders?: Zimmer Biomet's insider roster includes Betsy Bernard (Director), Wilfred can Zuilen (Insider), Robert Hagemann (Director), Bryan Hanson (CEO), Arthur Higgins (Director), Sreelakshmi Kolli (Director), Michael Michelson (Director), Chad Phipps (VP), and Sang Yi (Insider). Learn More on Zimmer Biomet's active insiders.
Are insiders buying or selling shares of Zimmer Biomet?: During the last year, insiders at the medical equipment provider sold shares 1 times. They sold a total of 26,156 shares worth more than $3,364,184.72. The most recent insider tranaction occured on February, 22nd when VP Chad F Phipps sold 26,156 shares worth more than $3,364,184.72. Insiders at Zimmer Biomet own 0.7% of the company. Learn More about insider trades at Zimmer Biomet.
Information on this page was last updated on 2/22/2024.

Bryan C. Hanson Insider Trading History at Zimmer Biomet

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/13/2020	Buy	1,000	$113.00	$113,000.00	54,568
2/7/2019	Buy	2,100	$119.02	$249,942.00	30,615
8/31/2018	Buy	410	$123.03	$50,442.30	25,487
2/20/2018	Buy	25,077	$119.68	$3,001,215.36

Bryan C. Hanson Buying and Selling Activity at Zimmer Biomet

Zimmer Biomet Company Overview

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Today's Range

Now: $108.96

$108.68

$109.48

50 Day Range

MA: $106.65

$101.77

$113.02

2 Week Range

Now: $108.96

$101.47

$133.90

Volume

250,431 shs

Average Volume

1,492,234 shs

Market Capitalization

$21.69 billion

P/E Ratio

20.71

Dividend Yield

0.87%

Beta

1.02

📉 Warning: Market Crash Predicted - Secure Your Savings

From Behind the Markets | Ad

The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.

Take these 4 steps to protect your retirement here >>>